JPRN-UMIN000020734已完成未知
Pivotal study about efficiency and safety of JTEC-01 made from revertant mosaicism in epidermolysis bullosa - Pivotal study of J-TEC-01 from revertant mosaicism for epidermolysis bullosa
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)patients who have allergy to particular antibiotics (Penicillin, Kanamycin, Amphotericin B) . (2)patients who have allergy to caw, mouse or pig. (3)patients who participate in other clinical trials within 6 month. (4)patients who have malignant tumor or past history of malignancy within 3years (except cutaneous malignancy). (5)those who are pregnant or nursing mum, or patients who are planning pregnancy during the study. (6)patients whom the investigators judge inappropriate as a subject for the study
研究者
相似试验
未知
3 期
Investigation of the Efficacy and Safety of JTT-751 in Non-dialysis CKD Patients (Double-blind Comparative Study)Chronic Kidney DiseaseJPRN-jRCT2080221396JAPAN TABACCO INC.90
未知
2 期
Investigation of the Efficacy and Safety of JTT-751in Hemodialysis PatientsChronic renal failureJPRN-jRCT2080220681JAPAN TABACCO INC.168
未知
3 期
Investigation of the Safety and Efficacy of JTT-751 in a Long-term Study in Hemodialysis Patients (2)Chronic Kidney DiseaseJPRN-jRCT2080221398JAPAN TABACCO INC.150
未知
3 期
Investigation of the Safety and Efficacy of JTT-751 in a Long-term Study in Hemodialysis Patients (1)Chronic Kidney DiseaseJPRN-jRCT2080221397JAPAN TABACCO INC.220
未知
3 期
Investigation of the Safety and Efficacy of JTT-751 in Non-dialysis CKD Patients (Extension Study)Chronic Kidney DiseaseJPRN-jRCT2080221399JAPAN TABACCO INC.90